Literature DB >> 22863674

Cannabinoid-1 receptors in the mouse ventral pallidum are targeted to axonal profiles expressing functionally opposed opioid peptides and contacting N-acylphosphatidylethanolamine-hydrolyzing phospholipase D terminals.

V M Pickel1, E T Shobin, D A Lane, K Mackie.   

Abstract

The ventral pallidum (VP) is a major recipient of inhibitory projections from nucleus accumbens (Acb) neurons that differentially express the reward (enkephalin) and aversion (dynorphin)-associated opioid peptides. The cannabinoid-1 receptor (CB1R) is present in Acb neurons expressing each of these peptides, but its location in the VP is not known. To address this question, we used electron microscopic dual immunolabeling of the CB1R and either dynorphin 1-8 (Dyn) or Met(5)-enkephalin (ME) in the VP of C57BL/6J mice, a species in which CB1R gene deletion produces a reward deficit. We also used similar methods to determine the relationship between the CB1R and N-acylphosphatidylethanolamine (NAPE)-hydrolyzing phospholipase D (NAPE-PLD), an anandamide-synthesizing enzyme located presynaptically in other limbic brain regions. CB1R-immunogold was principally localized to cytoplasmic endomembranes and synaptic or extrasynaptic plasma membranes of axonal profiles, but was also affiliated with postsynaptic membrane specializations in dendrites. The axonal profiles included many single CB1R-labeled axon terminals as well as terminals containing CB1R-immunogold and either Dyn or ME immunoreactivity. Dually labeled terminals comprised 26% of all Dyn- and 17% of all ME-labeled axon terminals. Both single- and dual-labeled terminals formed mainly inhibitory-type synapses, but almost 16% of these terminals formed excitatory synapses. Approximately 60% of the CB1R-labeled axonal profiles opposed or converged with axon terminals containing NAPE-PLD immunoreactivity. We conclude that CB1Rs in the mouse VP have subcellular distributions consistent with on demand activation by endocannabinoids that can regulate the release of functionally opposed opioid peptides and also modulate inhibitory and excitatory transmission.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863674      PMCID: PMC3496837          DOI: 10.1016/j.neuroscience.2012.07.050

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  66 in total

1.  Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens.

Authors:  D Robbe; G Alonso; F Duchamp; J Bockaert; O J Manzoni
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study.

Authors:  A G Hohmann; M Herkenham
Journal:  Synapse       Date:  2000-07       Impact factor: 2.562

3.  Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users.

Authors:  Paul S Frankel; Mario E Alburges; Lloyd Bush; Glen R Hanson; Stephen J Kish
Journal:  Neuropharmacology       Date:  2008-04-29       Impact factor: 5.250

4.  Disentangling pleasure from incentive salience and learning signals in brain reward circuitry.

Authors:  Kyle S Smith; Kent C Berridge; J Wayne Aldridge
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

5.  Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons.

Authors:  A J Irving; A A Coutts; J Harvey; M G Rae; K Mackie; G S Bewick; R G Pertwee
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 6.  Enzymological studies on the biosynthesis of N-acylethanolamines.

Authors:  Natsuo Ueda; Kazuhito Tsuboi; Toru Uyama
Journal:  Biochim Biophys Acta       Date:  2010-08-21

7.  Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.

Authors:  Kazuhito Tsuboi; Yasuo Okamoto; Natsuki Ikematsu; Manami Inoue; Yoshibumi Shimizu; Toru Uyama; Jun Wang; Dale G Deutsch; Matthew P Burns; Nadine M Ulloa; Akira Tokumura; Natsuo Ueda
Journal:  Biochim Biophys Acta       Date:  2011-07-23

8.  Evidence for coexistence of enkephalin and glutamate in axon terminals and cellular sites for functional interactions of their receptors in the rat locus coeruleus.

Authors:  E J Van Bockstaele; A Saunders; K G Commons; X B Liu; J Peoples
Journal:  J Comp Neurol       Date:  2000-01-31       Impact factor: 3.215

9.  Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P.

Authors:  S Nikolaus; J P Huston; R U Hasenöhrl
Journal:  Neurosci Lett       Date:  2000-03-31       Impact factor: 3.046

10.  Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.

Authors:  M Ellgren; A Artmann; O Tkalych; A Gupta; H S Hansen; S H Hansen; L A Devi; Y L Hurd
Journal:  Eur Neuropsychopharmacol       Date:  2008-11       Impact factor: 4.600

View more
  8 in total

Review 1.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

Review 2.  Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis.

Authors:  Cecilia J Hillard; Margaret Beatka; Jenna Sarvaideo
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

3.  The rostral subcommissural ventral pallidum is a mix of ventral pallidal neurons and neurons from adjacent areas: an electrophysiological study.

Authors:  Yonatan M Kupchik; Peter W Kalivas
Journal:  Brain Struct Funct       Date:  2012-11-10       Impact factor: 3.270

4.  Loss of Plasticity in the D2-Accumbens Pallidal Pathway Promotes Cocaine Seeking.

Authors:  Jasper A Heinsbroek; Daniela N Neuhofer; William C Griffin; Griffin S Siegel; Ana-Clara Bobadilla; Yonatan M Kupchik; Peter W Kalivas
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

Review 5.  The Endocannabinoid Signaling System in the CNS: A Primer.

Authors:  Cecilia J Hillard
Journal:  Int Rev Neurobiol       Date:  2015-11-06       Impact factor: 3.230

Review 6.  Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain.

Authors:  Adriana Della Pietra; Juha Savinainen; Rashid Giniatullin
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

7.  Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens.

Authors:  Ryan Kucera; Joseph Bouskila; Laurent Elkrief; Anders Fink-Jensen; Roberta Palmour; Jean-François Bouchard; Maurice Ptito
Journal:  Sci Rep       Date:  2018-06-06       Impact factor: 4.379

8.  Adolescent Exposure to WIN 55212-2 Render the Nigrostriatal Dopaminergic Pathway Activated During Adulthood.

Authors:  Enzo Javier Pérez-Valenzuela; María Estela Andrés Coke; Anthony A Grace; José Antonio Fuentealba Evans
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.